IONpath
2 known investors
IonPath develops MIBIscope, a spatial proteomics platform that uses multiplexed ion beam imaging to simultaneously measure dozens of protein targets in preserved tissue samples for translational research and discovery. The platform is used in oncology, immunology, and spatial biology studies across research institutions.
Investors · 2
In the news
Frequently asked questions
- What does IONpath do?
- IonPath develops MIBIscope, a spatial proteomics platform that uses multiplexed ion beam imaging to simultaneously measure dozens of protein targets in preserved tissue samples for translational research and discovery. The platform is used in oncology, immunology, and spatial biology studies across research institutions.
- Who are IONpath's investors?
- IONpath's investors include Norwich Ventures, Vertical Venture Partners.